Anti-Xa activity in obese patients after double standard dose of nadroparin for prophylaxis

By Heizmann M.   Baerlocher G.M.   Steinmann F.   Horber F.F.   Wuillemin W.A.  

Thrombosis Research, Vol. 106, Iss. 4, 2002-05 ,pp. : 179-181

Elsevier

Access to resources Recommend Favorite

VERY LOW DOSES OF UNFRACTIONATED HEPARIN POTENTIATE THE ANTI-Xa ACTIVITY OF LOW MOLECULAR WEIGHT HEPARIN (ENOXAPARIN)

By Perez-Requejo J.L.   Lucena-Solano O.   Perez-Garcia M.   Santarelli M.T.  

Thrombosis Research, Vol. 85, Iss. 3, 1997-02 ,pp. : 259-265

Elsevier

Access to resources Recommend Favorite

Evaluation of therapeutic anticoagulation with enoxaparin and associated anti-Xa monitoring in patients with morbid obesity: a case series

By Deal Eli  

Journal of Thrombosis and Thrombolysis, Vol. 32, Iss. 2, 2011-08 ,pp. : 188-194

Springer Publishing Company

Access to resources Recommend Favorite

Dose-Adjusted Thrombosis Prophylaxis in Trauma Surgery According to Levels of D-Dimer

By Peetz D.   Hafner G.   Hansen M.   Mayer A.   Rippin G.   Rommens P.M.   Prellwitz W.  

Thrombosis Research, Vol. 98, Iss. 6, 2000-06 ,pp. : 473-483

Elsevier

Access to resources Recommend Favorite

Does angiographic severity of coronary artery disease predict postoperative outcome after coronary artery bypass surgery?

By Biancari Fausto   Lahtinen Jarmo   Salmela Esa   Niemelä Matti   Pokela Risto   Rainio Pekka   Lepojärvi Martti   Satta Jari   Juvonen Tatu  

Scandinavian Cardiovascular Journal, Vol. 37, Iss. 5, 2003-09 ,pp. : 275-282

Informa Healthcare

Access to resources Recommend Favorite